<DOC>
	<DOCNO>NCT02353897</DOCNO>
	<brief_summary>This study aim look patient physician satisfaction long term Glabellar line ( GL ) treatment Dysport real life set . It also allow well understanding patient expect treatment , injection practice use doctor .</brief_summary>
	<brief_title>Patient Physician 's Satisfaction After Long Term Treatment Glabellar Lines With Dysport®</brief_title>
	<detailed_description />
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<criteria>Adult patient moderate severe GL naïve type aesthetic treatment/procedure ( invasive noninvasive ) GL provide write informed consent take part . Patient prior independent study decide undergo long term treatment GL ( least three cycle ) . Patient able comply protocol ( completion web questionnaire ) . Patient physician intend treat Dysport independent participation study . Patient already include study . Participation interventional trial within 30 day prior study entry . Patient risk term precaution , warning , contraindication ( follow local Summary Product Characteristics ( SmPC ) Dysport ) . Female patient pregnant , nurse plan pregnancy study . Hypersensitivity Dysport® excipients . Presence infection propose injection site . Presence myasthenia gravis , Eaton Lambert syndrome amyotrophic lateral sclerosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>